P11.66.A Immune checkpoint inhibitors related peripheral nerve disorders: clinical and electrophysiological particularities

MLA

C Birzu, et al. “P11.66.A Immune Checkpoint Inhibitors Related Peripheral Nerve Disorders: Clinical and Electrophysiological Particularities.” Neuro-Oncology, vol. 24, Sept. 2022, pp. ii73-ii74. EBSCOhost, https://doi.org/10.1093/neuonc/noac174.255.

APA

C Birzu, A Farina, A Pegat, P Devic, T Lenglet, K Viala, R Debs, G Fargeot, A Picca, L Le Guennec, M Mongin, B Villette, B Joubert, T Maisonobe, & D Psimaras. (2022). P11.66.A Immune checkpoint inhibitors related peripheral nerve disorders: clinical and electrophysiological particularities. Neuro-Oncology, 24, ii73-ii74. https://doi.org/10.1093/neuonc/noac174.255

Chicago

C Birzu, A Farina, A Pegat, P Devic, T Lenglet, K Viala, R Debs, et al. 2022. “P11.66.A Immune Checkpoint Inhibitors Related Peripheral Nerve Disorders: Clinical and Electrophysiological Particularities.” Neuro-Oncology 24 (September): ii73-ii74. doi:10.1093/neuonc/noac174.255.